Chad M Robins's Net Worth
$51.5 Million
Who is Chad M Robins?
Chad M Robins has an estimated net worth of $51.5 Million. This is based on reported shares across multiple companies, which include Adaptive Biotechnologies Corp, CM Life Sciences III Inc., and ARYA Sciences Acquisition Corp II.
SEC CIK
Chad M Robins's CIK is 0001780649
Past Insider Trading and Trends
2020 was Chad M Robins's most active year for acquiring shares with 42 total transactions. Chad M Robins's most active month to acquire stocks was the month of February. 2020 was Chad M Robins's most active year for disposing of shares, totalling 114 transactions. Chad M Robins's most active month to dispose stocks was the month of February. 2020 saw Chad M Robins paying a total of $617,272.15 for 1,089,505 shares, this is the most they've acquired in one year. In 2020 Chad M Robins cashed out on 1,650,495 shares for a total of $32,042,045.09, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adaptive Biotechnologies Corp (ADPT) Snapshot price: $4.21
CEO and ChairmanChad M Robins owns 2,576,701 units of Common Stock which is worth $10,847,911.21. From 2022 to 2024 Chad M Robins acquired a total of 1,920,018 shares in Adaptive Biotechnologies Corp at a cost of $717,502.95, Chad also disposed a total of 1,171,067 shares of Adaptive Biotechnologies Corp equalling to $41,369,647.78.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.47% | 305.94K |
$3.43 | -$167,007.18 | 2.58M |
Mar 4 - Mar 5
| |||
Form 4
| +18.51% | 354.61K |
—
|
—
| 2.27M |
Mar 6
| |||
Form 4
| -3.09% | -59.26K |
$7.97 | -$617,982.35 | 1.92M |
Scheduled
|
Mar 7 - Mar 9
| ||
Form 4
| +14.50% | 242.69K |
$12.01 | -$53,132.24 | 1.92M |
Mar 4 - Mar 7
| |||
Form 4
| -2.53% | -43.50K |
$38.43 | -$1,671,495.54 | 1.67M |
Scheduled
|
Sep 8 - Sep 10
| ||
Form 4
| -0.09% | -1.50K |
$38.24 | -$57,398.24 | 1.72M |
Scheduled
|
Jul 12
| ||
Form 4
| -1.72% | -30.00K |
$38.47 | -$1,153,964.65 | 1.72M |
Scheduled
|
Jun 15 - Jun 17
| ||
Form 4
| -0.85% | -15.00K |
$41.81 | -$627,106.72 | 1.75M |
Scheduled
|
Apr 6 - Apr 8
| ||
Form 4
| -0.84% | -15.00K |
$42.89 | -$643,416.31 | 1.76M |
Scheduled
|
Mar 17 - Mar 19
| ||
Form 4
| +4.02% | 68.68K |
—
|
—
| 1.78M |
Mar 4
| |||
Form 4
| -1.72% | -30.00K |
$62.31 | -$1,869,322.41 | 1.71M |
Scheduled
|
Feb 8 - Feb 10
| ||
Form 4
| -1.70% | -30.00K |
$59.38 | -$1,781,546.25 | 1.74M |
Scheduled
|
Jan 26 - Jan 28
| ||
Form 4
| -0.47% | -8.40K |
$70.43 | -$591,600.00 | 1.77M |
Scheduled
|
Jan 19
| ||
Form 4
|
—
|
0
|
$30.11 | -$2,951,463.91 | 1.78M |
Scheduled
|
Dec 28 - Dec 30
| ||
Form 4
|
—
|
0
|
$23.66 | -$2,334,915.89 | 1.78M |
Scheduled
|
Nov 17 - Nov 19
| ||
Form 4
|
—
|
0
|
$25.23 | -$4,608,564.28 | 1.78M |
Scheduled
|
Oct 6 - Oct 8
| ||
Form 4
|
—
|
0
|
$25.24 | -$124,547.00 | 1.78M |
Scheduled
|
Sep 29 - Oct 1
| ||
Form 4
|
—
|
0
|
$23.11 | -$2,273,563.60 | 5.31M |
Scheduled
|
Sep 16 - Sep 18
| ||
Form 4
| +1.01% | 18.01K |
$21.78 | -$1,172,832.92 | 1.78M |
Scheduled
|
Aug 10 - Aug 12
| ||
Form 4
|
—
|
0
|
$19.04 | -$2,021,408.20 | 1.78M |
Scheduled
|
Jul 29 - Jul 31
| ||
Form 4
|
—
|
0
|
$23.09 | -$1,508,293.74 | 1.78M |
Scheduled
|
Jun 22
| ||
Form 4
|
—
|
0
|
$22.45 | -$3,082,917.20 | 1.78M |
Scheduled
|
Jun 17 - Jun 19
| ||
Form 4
| -5.32% | -100.00K |
$20.28 | -$5,984,924.00 | 1.78M |
Scheduled
|
May 19 - May 21
| ||
Form 4
|
—
|
0
|
$17.97 | -$1,587,117.24 | 1.88M |
Scheduled
|
May 7
| ||
Form 4
| +0.05% | 1K |
$14.30 | -$1,356,201.00 | 1.88M |
Scheduled
|
Apr 13 - Apr 15
| ||
Form 4
|
—
|
0
|
$11.42 | -$369,731.16 | 1.88M |
Scheduled
|
Mar 19 - Mar 20
| ||
Form 4
|
—
|
0
|
$15.94 | -$347,277.60 | 1.88M |
Scheduled
|
Feb 13
| ||
Form 4
|
—
|
0
|
$15.78 | -$687,438.40 | 1.88M |
Scheduled
|
Feb 11 - Feb 12
| ||
Form 4
|
—
|
0
|
$15.52 | -$1,013,576.80 | 1.88M |
Scheduled
|
Jan 27 - Jan 29
| ||
Form 4
| +1.08% | 20K |
$0.33 | $6,600.00 | 1.88M |
Oct 23
| |||
Form 4
| +3.95% | 70.68K |
—
|
—
| 1.86M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CM Life Sciences III Inc. (EQRX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ARYA Sciences Acquisition Corp II (CERE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |